OOIR: Observatory of International Research

Papers

(The TQCC of Endocrine Reviews is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	445
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	305
Endocrine Manifestations and New Developments in Mitochondrial Disease	261
How Protein Methylation Regulates Steroid Receptor Function	233
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	227
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	194
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	193
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	172
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	169
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	165
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures	151
The Molecular Biology of Midgut Neuroendocrine Neoplasms	147
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome	130
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	114
Stem Cells and Organs-on-chips: New Promising Technologies for Human Infertility Treatment	106
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	89
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	82
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	81
The Biology and Clinical Implications of PCSK7	74
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	73
Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity	71
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	71
Estrogen Receptor Signaling in the Immune System	69
New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature	67
Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”	67

Contemporary Biological Insights and Clinical Management of Craniopharyngioma	64
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	59
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	57
Time-restricted Eating for the Prevention and Management of Metabolic Diseases	57
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	55
The Metabolic Role and Therapeutic Potential of the Microbiome	54
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	52
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	51
Adiponectin and Adiponectin Receptors in Atherosclerosis	49
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	48
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	48
The Cortisol Awakening Response: Regulation and Functional Significance	47
Imaging of Pheochromocytomas and Paragangliomas	46
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	46